BrightPath Biotherapeutics Co., Ltd.
4594 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 川崎市川崎区殿町三丁目２５番２２号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BrightPath Biotherapeutics Co., Ltd. is a pioneering Japanese biotechnology company specializing in innovative cancer therapies. The company focuses on developing iPS-NKT, a groundbreaking allogeneic cell therapy that utilizes induced pluripotent stem cells (iPSCs) to generate natural killer T-cells (NKT cells) for cancer treatment. Recognizing the therapeutic potential of NKT cells, which exhibit diverse anti-tumor effects yet are typically scarce in the bloodstream, BrightPath harnesses state-of-the-art iPSC technology to produce these cells in large, homogeneous quantities from its iPS Master Cell Bank. By leveraging this novel approach, BrightPath aims to advance cancer treatment and improve patient outcomes through effective and scalable cell therapies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for BrightPath Biotherapeutics Co., Ltd..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-20 09:01 |
Regulatory News Service
臨時報告書
|
Japanese | 22.8 KB | |
| 2025-06-19 08:36 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-06-19 08:32 |
Regulatory News Service
内部統制報告書－第22期(2024/04/01－2025/03/31)
|
Japanese | 23.4 KB | |
| 2025-06-19 08:25 |
Annual Report
有価証券報告書－第22期(2024/04/01－2025/03/31)
|
Japanese | 933.5 KB | |
| 2024-11-08 07:35 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-11-08 07:34 |
Interim Report
半期報告書－第22期(2024/04/01－2025/03/31)
|
Japanese | 224.9 KB | |
| 2024-06-21 09:07 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 254.0 KB | |
| 2024-06-21 08:34 |
Regulatory News Service
内部統制報告書－第21期(2023/04/01－2024/03/31)
|
Japanese | 23.2 KB | |
| 2024-06-21 08:33 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-06-21 08:32 |
Annual Report
有価証券報告書－第21期(2023/04/01－2024/03/31)
|
Japanese | 990.5 KB | |
| 2024-06-19 08:00 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 513.9 KB | |
| 2024-02-09 07:12 |
Regulatory News Service
確認書
|
Japanese | 9.1 KB | |
| 2024-02-09 07:11 |
Quarterly Report
四半期報告書－第21期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 195.3 KB | |
| 2023-11-15 07:27 |
Regulatory News Service
訂正有価証券届出書（組込方式）
|
Japanese | 183.0 KB | |
| 2023-11-14 07:56 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 332.0 KB |
Automate Your Workflow. Get a real-time feed of all BrightPath Biotherapeutics Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BrightPath Biotherapeutics Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
